The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling

Abstract

HYPOTHESIS:The multi-faceted components of the metabolic syndrome now include markers of inflammation and endothelial activation. Despite this growing body of epidemiological data, standard statistical methods fail to evaluate the nature of these associations adequately. In this pilot study, we hypothesize that obesity may lead to endothelial activation which is in part mediated by dyslipidaemia and proinflammatory cytokines. These factors interact to give rise to hyperinsulinaemia, hypertension and an anti-fibrinolytic state. To test this hypothesis, we used confirmatory factor analysis and structural equation modelling to fit these data to a model designed on theoretical grounds. METHODS: Metabolic syndrome variables, cytokines (IL6 and TNFa), markers of inflammation and endothelial activation were measured in 107 Caucasian non-diabetic subjects aged 40 -75 y. Using confirmatory factor analysis, we identified six factors to represent composite measurements of blood pressure, obesity, dyslipidaemia, hyperinsulinaemia, endothelial activation and the anti-fibrinolytic state. We fitted these variables to two separate models, one using IL-6 and the other TNFa as the cytokine, and examined the inter-relationships (path analysis) amongst these variables, based on the above hypothesis. RESULTS: Men were centrally more obese and had increased markers of endothelial activation, inflammation and the antifibrinolytic state as well as hyperinsulinaemia and dyslipidaemia, compared with women. Obesity indexes (both body mass index and waist -hip ratio) were strongly associated with multiple cardiovascular risk factors. Both IL6 and TNFa were correlated with age, male gender, obesity indexes and markers of endothelial activation. Only IL-6 was associated with smoking while TNFa was correlated with hyperinsulinaemia. In the TNFa model, 61% of the obesity variance was explained by male gender, 36% of TNFa variance by age and dyslipidaemia, 43% of dyslipidaemia variance by age and obesity, 33% of hyperinsulinaemia variance by dyslipidaemia and a non-smoking state, 29% of anti-fibrinolytic state variance by hyperinsulinaemia, 65% of endothelial activation variance by TNFa, dyslipidaemia and hyperinsulinaemia, 34% of blood pressure variance by hyperinsulinaemia and endothelial activation. In the IL-6 model, we observed similar relationships except that 23% of IL6 variance was explained by smoking and age. CONCLUSIONS: Using confirmatory factor analysis and structural equation modelling, we found that obesity, dyslipidemia and cytokines were the principal explanatory variables for the various components of the metabolic syndrome, with IL6 and TNFa having different explanatory variables and effects. These complex inter-relationships were in part mediated by hyperinsulinaemia and endothelial activation. While this hypothetical model was based on scientific evidence, supported by rigorous analysis, it requires further confirmation in large-scale prospective studies. Given the complexity of the biological system and its interactions wi...

Establishment of a cut‐point value of serum TNF‐α levels in the metabolic syndrome

“…In this study, the serum concentration of TNF-a, an inflammatory cytokine implicated in IR, was analyzed in individuals diagnosed with or without MS. A significantly increased concentration of TNF-a was found in the MS group, similar to a previously reported study (15). Indeed, several reports indicate that certain dyslipidemias exhibit pro-inflammatory stages that are associated with elevated TNF-a levels (16)(17)(18)(19). Nevertheless, in our study hypertriglyceridemic and hypercholesterolemic individuals did not exhibit increased TNF-a serum levels.…”

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors

“…Current evidence supports that metabolic risk factors, including dyslipidemia, glucose intolerance, and hyperinsulinemia, are linked with circulating levels of inflammatory and thrombotic cytokines (4,6,25,45). Relationships between cytokine gene expression in adipose tissue and metabolic risk and insulin resistance have been reported as well (12,13,18,19,35).…”

“…In addition, a proinflammatory state, as indicated by elevated circulating interleukin (IL)-6, tumor necrosis factor (TNF)-␣, and the acute-phase reactant C-reactive protein, and a prothrombotic state, as indicated by increased plasminogen activator inhibitor type 1 (PAI-1), are usually present with the syndrome (9). Circulating levels of these cytokines have been linked with the individual risk components (6,25) as well as the clustering of these risk factors (4,45).…”

Phenotype–genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling

“…Structural equation modelling, commonly employed in sociology and management sciences, is now increasingly used in the field of biomedicine [2,3]. However, conventional SEM only deals with continuous variables and cannot adequately handle missing and non-ranking categorical variables such as alleles (a, A) and genotypes (aa, AA, aA), where coding of 0, 1 and 2 for aa, AA and aA, respectively, does not imply 0<1<2.…”